eCite Digital Repository

New trends in pharmacological treatments for osteoarthritis

Citation

Cai, X and Yuan, S and Zeng, Y and Wang, C and Yu, N and Ding, C, New trends in pharmacological treatments for osteoarthritis, Frontiers in Pharmacology, 12 Article 645842. ISSN 1663-9812 (2021) [Refereed Article]


Preview
PDF (Published version)
968Kb
  

Copyright Statement

Copyright 2021 Cai, Yuan, Zeng, Wang, Yu and Ding. Copyright 2021 Cai, Yuan, Zeng, Wang, Yu and Ding.

DOI: doi:10.3389/fphar.2021.645842

Abstract

Osteoarthritis (OA) is the leading cause of function loss and disability among the elderly, with significant burden on the individual and society. It is a severe disease for its high disability rates, morbidity, costs, and increased mortality. Multifactorial etiologies contribute to the occurrence and development of OA. The heterogeneous condition poses a challenge for the development of effective treatment for OA; however, emerging treatments are promising to bring benefits for OA management in the future. This narrative review will discuss recent developments of agents for the treatment of OA, including potential disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics for pain relief. This review will focus more on drugs that have been in clinical trials, as well as attractive drugs with potential applications in preclinical research. In the past few years, it has been realized that a complex interaction of multifactorial mechanisms is involved in the pathophysiology of OA. The authors believe there is no miracle therapeutic strategy fitting for all patients. OA phenotyping would be helpful for therapy selection. A variety of potential therapeutics targeting inflammation mechanisms, cellular senescence, cartilage metabolism, subchondral bone remodeling, and the peripheral nociceptive pathways are expected to reshape the landscape of OA treatment over the next few years. Precise randomized controlled trials (RCTs) are expected to identify the safety and efficacy of novel therapies targeting specific mechanisms in OA patients with specific phenotypes.

Item Details

Item Type:Refereed Article
Keywords:DMOADs, clinical prospect, novel therapeutics, osteoarthritis, therapy selection
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacology and therapeutics
Objective Division:Health
Objective Group:Clinical health
Objective Field:Treatment of human diseases and conditions
UTAS Author:Ding, C (Professor Chang-Hai Ding)
ID Code:146218
Year Published:2021
Web of Science® Times Cited:13
Deposited By:Menzies Institute for Medical Research
Deposited On:2021-08-25
Last Modified:2021-09-08
Downloads:15 View Download Statistics

Repository Staff Only: item control page